Baxter's Bioscience Business Acquires SuppreMol|
Wednesday, March 04, 2015
Acquisition includes SuppreMol's early-stage pipeline of protein therapeutics for autoimmune and allergic diseases.
NIH Announces $41.5 Million in Funding for the Human Placenta Project
Tuesday, March 03, 2015
Better understanding of the placenta promises to improve the health of mothers and children.
MRC Technology Launches Respiratory ‘Call for Targets’
Monday, March 02, 2015
Project focused on potential small molecule or antibody targets in pathways important in the development or progression of respiratory disease.
TxCell to Present at ROTH Capital Partners Investor Conference in US
Friday, February 27, 2015
TxCell invited to speak at largest US meeting for investors in emerging growth companies.
Bristol-Myers Squibb to Expand its Immuno-Oncology Pipeline
Thursday, February 26, 2015
Gains full rights to Flexus’ lead preclinical IDO1 inhibitor F001287 and the company’s broad IDO/TDO discovery program.
Scientists Uncover New Role for Neurotransmitter that Helps Fight Infection
Wednesday, February 25, 2015
Scientists have shed new light on the complexities of the immune system that could help develop vaccines to boost natural defences against disease.
NIH-funded Scientists Create Potential Long-acting HIV Therapeutic
Tuesday, February 24, 2015
New molecule also might prevent HIV infection.
Epigenetic Study Highlights Drug Targets for Allergies and Asthma
Saturday, February 21, 2015
Scientists have discovered over 30 new genes that predispose people to allergies and asthma, some of which could be targets for new drugs.
Cell Medica Announces Start of Commercial Cell Therapy Manufacture
Friday, February 20, 2015
Manufacturing will be focused on Cytovir™ CMV for the treatment of patients with CMV infections.